Benjamin Speich

Benjamin Speich

University of Oxford

H-index: 33

Europe-United Kingdom

About Benjamin Speich

Benjamin Speich, With an exceptional h-index of 33 and a recent h-index of 28 (since 2020), a distinguished researcher at University of Oxford, specializes in the field of Clinical trials, Research on research, reporting, Systematic reviews, Platform trials.

His recent articles reflect a diverse array of research interests and contributions to the field:

Characteristics, Progression, and Output of Randomized Platform Trials: A Systematic Review

Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial

Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

Glucagon-like peptide-1 analogues: a new way to quit smoking?(SKIP)—a structured summary of a study protocol for a randomized controlled study

Antibody response after third vaccination with mRNA-1273 or BNT162b2: extension of a randomized controlled SARS-CoV-2 noninferiority vaccine trial in patients with different …

Overinterpretation of findings in machine learning prediction model studies in oncology: a systematic review

Remdesivir in Hospitalized COVID-19 Patients: Individual Patient Data Meta-Analysis

Benjamin Speich Information

University

Position

Postdoctoral Research Fellow Centre for Statistics in Medicine

Citations(all)

3819

Citations(since 2020)

2314

Cited By

2322

hIndex(all)

33

hIndex(since 2020)

28

i10Index(all)

54

i10Index(since 2020)

53

Email

University Profile Page

Google Scholar

Benjamin Speich Skills & Research Interests

Clinical trials

Research on research

reporting

Systematic reviews

Platform trials

Top articles of Benjamin Speich

Characteristics, Progression, and Output of Randomized Platform Trials: A Systematic Review

2024/3/4

Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial

Eclinicalmedicine

2024/2/1

Mirjam Laager
Mirjam Laager

H-Index: 5

Benjamin Speich
Benjamin Speich

H-Index: 23

Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1

AIDS

2024/2/1

Alexandra Trkola
Alexandra Trkola

H-Index: 32

Benjamin Speich
Benjamin Speich

H-Index: 23

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

2023/5/1

Glucagon-like peptide-1 analogues: a new way to quit smoking?(SKIP)—a structured summary of a study protocol for a randomized controlled study

Trials

2023/4/20

Benjamin Speich
Benjamin Speich

H-Index: 23

Antibody response after third vaccination with mRNA-1273 or BNT162b2: extension of a randomized controlled SARS-CoV-2 noninferiority vaccine trial in patients with different …

Open Forum Infectious Diseases

2023/4/1

Overinterpretation of findings in machine learning prediction model studies in oncology: a systematic review

2023/3/17

Remdesivir in Hospitalized COVID-19 Patients: Individual Patient Data Meta-Analysis

Topics in Antiviral Medicine

2023

Antibody response after the third SARS-CoV-2 vaccine in solid organ transplant recipients and people living with HIV (COVERALL-2)

Open Forum Infectious Diseases

2023/11

Guidance needed: where should randomized studies which do not assess a health outcome be registered?

Journal of Clinical Epidemiology

2023/9/1

Benjamin Speich
Benjamin Speich

H-Index: 23

Reporting guidelines used varying methodology to develop recommendations

Journal of Clinical Epidemiology

2023/7/1

Reminding peer reviewers of reporting guideline items to improve completeness in published articles: primary results of 2 randomized trials

JAMA Network Open

2023/6/1

Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis

2022/4/27

Methodological conduct of prognostic prediction models developed using machine learning in oncology: a systematic review

2022/4/8

ANTIBODY RESPONSE to SARS-CoV-2 VACCINES and IMMUNODEFICIENCY: A RANDOMIZED TRIAL

Topics in Antiviral Medicine

2022

RF32| PSUN59 Glucagon-Like Peptide-1 Analogues: A New Way to Quit Smoking? SKIP–a Randomised Controlled Study

Journal of the Endocrine Society

2022/11/11

Benjamin Speich
Benjamin Speich

H-Index: 23

Effects of Remdesivir in Hospitalized patients with COVID-19: systematic review and Individual Patient Data Meta-Analysis of Randomized clinical trials

2022/10/11

Use of text mining tools in the development of search strategies–Comparison of different approaches

Journal of clinical epidemiology

2022/9/1

A meta-research study of randomized controlled trials found infrequent and delayed availability of protocols

Journal of Clinical Epidemiology

2022/9/1

Egg excretion indicators for the measurement of soil-transmitted helminth response to treatment

PLoS Neglected Tropical Diseases

2022/8/2

Benjamin Speich
Benjamin Speich

H-Index: 23

See List of Professors in Benjamin Speich University(University of Oxford)